GAMMA Investing LLC and various other institutions have substantial holdings in
Henry Schein, Inc.. The firm is deemed a
strong value stock even as it underperforms in comparison to its competitors on certain days. The company's stock price has seen fluctuations, going down 4.3% since the last earnings report but also observed an increase of 5.2%.
Vanguard Group Inc. and several other asset management companies have purchased shares of Henry Schein. Piper Sandler has reiterated an “
Overweight” rating for the stock. Henry Schein also announced the
acquisition of Condor Dental, and faced a
cyber-attack in Q4. Despite challenges, the company reported solid performance in its Q1 2024 earnings, while adopting a cautious outlook for 2024 sales. The company also announced
expansion of data analytics to private practices and entrance into the
Orthopedic market with a new buyout. A cybersecurity incident subject cast shadows on its Q4 performance. Its full-year 2023 earnings missed expectations and saw a premarket fall due to the impact of the cyber-attack. Henry Schein also completed the
acquisition of TriMed and presented its financial outlook at investor conferences.
Henry Schein HSIC News Analytics from Sun, 15 Oct 2023 07:00:00 GMT to Sun, 23 Jun 2024 19:19:55 GMT -
Rating 2
- Innovation 5
- Information 8
- Rumor -3
